Reviews Write New Review
[email protected]
Patricia M. Danzon
Professor of Health Care Management, Wharton School of Business
Patricia Danzon is the Celia Moh Professor at The Wharton School, University of Pennsylvania. Professor Danzon received a B.A. from Oxford University, England, and a Ph.D. in Economics from the University of Chicago. She has held faculty positions at Duke University and the University of Chicago.
Professor Danzon is an internationally recognized expert in the fields of economics of health care, the biopharmaceutical industry, and insurance. She is a member of the Institute of Medicine and the National Academy of Social Insurance, and a Research Associate at the National Bureau of Economic Research. She has served as a consultant to many governmental agencies, NGOs and private corporations in the US and internationally. Professor Danzon has served on the Board of Directors of Medarex, Inc., the Policy and Global Affairs Board of the National Academy of Sciences, and the Policy Board of the Office of Health Economics in London.
Professor Danzon has been an Associate Editor of the American Economic Review, the Journal of Health Economics and the International Journal of Health Care Finance and Economics. She has published widely in scholarly journals on a broad range of subjects related to health care, pharmaceuticals, biotechnology, insurance, and the economics of law. She co-edited the Handbook on the Economics of the Biopharmaceutical Industry (2012), for Oxford University Press. Selected publications include: “Exits from Vaccine Markets in the US: The Role of Competition vs. Regulation” (with N. Pereira), International J. of the Economics of Business 2011; “Setting Cost-Effectiveness Thresholds As A Means To Achieve Appropriate Drug Prices In Rich And Poor Countries” (with A. Towse and A. Mulcahy) Health Affairs 2011; “Drug Pricing and Value in Oncology” (with E. Taylor) The Oncologist 2010; "Productivity in Pharmaceutical-Biotechnology R&D: The Role of Experience and Alliances" (with S.Nicholson and N.Pereira) J. of Health Economics 2005; “Biotech-Pharma Alliances as a Signal of Asset and Firm Quality” (with S. Nicholson and J. McCulloch, J. of Business 2005.
News
Related Speakers View all
Kevin Schulman
Professor Of Medicine at the Clinical Excellence Res...
|
|
Gary Lynn
Tenured professor at the Stevens Institute & Chairma...
|
|
Leemore Dafny
Bruce V. Rauner Professor of Business Administration...
|
|
Amy Finkelstein
Professor of Economics Massachusetts Institute of Te...
|
|
Vic Strecher, Ph.D. MPH
Founder, JOOL Health; Professor, University of Michi...
|
|
Emily Oster
Professor of Economics at Brown University; Author o...
|
|
Nicholas Burns
Professor of the Practice of Diplomacy & Internation...
|
|
Dr. Paul Wolpe
Director of the Emory Center for Ethics
|
|
David Cutler
Harvard Professor of Applied Economics & Author
|
|
Regina Herzlinger
Economist / Authority on Healthcare / Author
|
|
Dan Ariely
Behavioral Economist; Professor at Duke University; ...
|
|
Shauna J. Rowland
Leadership Speaker, Coach & Consultant
|
|
Roger Marshall
US Senator for Kansas & Veteran
|
|
Meena Seshamani
Deputy Administrator & Director at CMS Center for Me...
|
|
Dr. James Weinstein
Senior Vice President of Microsoft Healthcare; Visit...
|
|
Diana Greene Foster
Demographer & Reproductive Health Researcher; Profes...
|
|
Bruce Japsen
Senior Healthcare Contributor at Forbes; Adjunct Jou...
|
|
Alex Lawrence, PhD
Weber State University Professor, Artificial Intelli...
|
|
John Kao
Founder & CEO of Alignment Health
|
|
Errol L. Pierre
Business Executive, Leadership Coach, Healthcare Str...
|